The Effect of Application of PROLANIS Program on Type 2 Diabetes Mellitus in Bekasi Primary Healthcare
Abstract
Prolanis is Chronic Disease Management Program; where this program is an integrated health service program and involves other parties such as BPJS, health facilities and patients. Clinical outcomes ultimately impact the quality of life and, in general, if the quality of life grows well, which is indicated by controlled glucose levels. The result of this research is to know the impact of applying Prolanis to measure the quality of life in type 2 Diabetes Mellitus patients at Pekayon Jaya Health Center and Pengasinan Health Center.
The method used in this research is a cohort study with data analysis of SPSS version 24. The study was conducted on 80 patients consisting of 40 prolanis patients at Pekayon Jaya Health Center and 40 non-prolanis patients at Pengasinan Health Center within a period of 3 (three) months. Data on the level of knowledge and compliance were collected using a questionnaire. GDP data was taken from monthly patient control visits, and quality of life data was taken using the European Quality of Life-5 Dimension-5 Level (EQ-5D-5L) instrument and the conversion of health utility to the Indonesian value set.
The result is there is a significant effect of applying prolanis program in prolanis and non-prolanis patients on the level of knowledge, compliance, and GDP in describing the quality of life. The utility value of prolanis patients was 0.945±0.101 higher than non-prolanis patients, 0.769±0.197. Based on the level of knowledge of prolanis and non-prolanis patients (34.35±2.13: 28.47±4.09), prolanis and non-prolanis patient compliance (6.38±1.66: 5.11±1.45), and fasting blood sugar values of prolanis and non-prolanis patients (110.05±20.67 : 144.20±29.10). The application of Prolanis is said to have a considerable influence on the level of discipline, knowledge, and GDP to the quality of life of patients, both prolanis and non-prolanis.
References
World Health Organization. (WHO) 2015. Fakta dan Angka Diabetes di Indonesia. 2015.
American Diabetes Association (ADA) 2018. Diagnosis and Classification of Diabetes Melitus Care, volume 37, supplement; January 2014,P.514-27
International Diabetes Federation (IDF), Eighth edition 2017. 2017.1-150 p.
Dinas Kesehatan Provinsi Jawa Barat 2016.
International Diabetes Federation (IDF). 2015. Diabetes Atlas 7 th Edition Brussels: International Diabetes Federation. Diakses tanggal 11 November 2019.
Perkeni, 2011. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Kementerian Kesehatan Republik Indonesia: Jakarta.
Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar. Jakarta. 2018.
Balai Litbang Kesehatan. Hasil Riset Kesehatan Dasar 2018. 2013;223-5.
Dinas Kesehatan Kota Bekasi. Profil Kesehatan Kota Bekasi 2018. Seksi Subagian Perencanaan Dinas Kesehatan Kota Bekasi. 2018.
BPJS. Panduan Praktis Prolanis (Program Pengelolaan Penyakit Kronis). BPJS Kesehatan. 2015.
Herty Nur Tanty. Pengaruh Prolanis Terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2 Di Puskesmas Kecamatan Pulo Gadung. Tesis. Universitas Pancasila. 2018.
Aditya Primahuda. 2016. Hubungan antara kepatuhan mengikuti program prolanis BPJS dengan stabilitas Gula darah pada penderita Diabetes Melitus di Puskesmas Babat Kabupaten Lamongan. Universitas Diponogoro.
Musfirah Ahmad & Nurwahyuni. 2018. Korelasi Antara Pelaksanaan Prolanis Dengan Pengendalian Kadar Gula Darah Penderita Diabetes Melitus Tipe 2 Di Puskesmas Antang Dan Pampang Kota Makassar.
Siyami N.F. 2017. Perbedaan Kadar Glukosa Darah Dan Status Gizi Penderita DM Tipe 2 Yang Menjadi Peserta Prolanis Dan Bukan Peserta Prolanis di Puskesmas Gondokusumo.
Fajriansyah. 2019. Pengukuran Kualitas Hidup Pasien Program Pengelolaan Penyakit Kronis Diabetes Melitus Tipe 2 Di Puskesmas Tamalanrea Makassar.
Nur Hamida. 2019. Pengukuran Kualitas Hidup Pasien Program pengelolaan Penyakit Kronis (Prolanis) Di Puskesmas Menggunakan Instrumen EQ-5D-5L.
Mohammad Reza Abedini. Bita Bijari. Zahra Miri. 2020. The Quality of Life of The Patients With Diabetes Type 2 Using EQ-5D-5L in Birjand
Irawan, D. Prevalensi dan Faktor Risiko Kejadian Diabetes Mellitus Tipe 2 di Daerah Urban Indonesia (analisa data sekunder riskesdas 2007). Depok: Universitas Indonesia Press; 2010.
Sujaya, I Nyoman. 2009. “Pola Konsumsi Makanan Tradisional Bali sebagai Faktor Risiko Diabetes Melitus Tipe 2 di Tabanan.” Jurnal Skala Husada Vol. 6 No.1 hal: 75-81
Fadia, dkk. Hubungan Lama Kepesertaan Prolanis Dengan Tingkat Pengetahuan Gizi dan Kepatuhan diet Pasien Diabetes melitus di Puskesmas Gilingan Surakarta; 2018.
Lee, G.M., Salomom, J.A., Gay, C., Hammit, J.K.Preferences for health otcomes associated with Group A Streptococcal disease and vaccination. Health Qual Life Otcomes.2010;8:28.
Sukawati, N.W., dkk (2021). Perbandingan Kuesioner EQ-5D-5L dan SF-6D untuk Mengukur Kualitas Hidup Pasien Penyakit Ginjal Kronik di RSUD kota Yogyakarta. Jurnal Farmasi Indonesia Vol. 18 No. 2 hal: 200-205.
Donald E. Morisky, ScD, ScM,MSPH. Professor Departement of Community Health Sciences, UCLA. School of Public Health, 650. Charles E. Young Drive, South, Los Angeles, CA.90095-1772.USA.
Purba, F.D., Hunfeld, J.A.M., Iskandarsyah, A., Fitriana, T.S., Sadarjoen, S.S., Ramos-Goni, J.M. et al., The Indonesian EQ-5D-5L Value Set. PharmacoEconomics.2017;35(11):1153-1165.
